LamKap Bio presented data on NILK-2301, NILK-2401 & NILK-3301
The American Association for Cancer Research (AACR) hosted the AACR annual meeting 2023 April 14-19, 2023. LamKap Bio is very pleased to have presented preclinical data on the combination of NILK-2301 (CEACAM5xCD3) and NILK-2401 (CEACAM5xCD47) as well as NILK-2301 and NILK-3301 (CEACAM5xCD28) bispecific antibodies for immunotherapy of patients with carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5 aka CEA) expressing solid tumors.
“Combination of κλ bispecific antibodies targeting innate (CEAxCD47, NILK-2401) and adaptive immunity (CEAxCD3, NILK-2301 and CEAxCD28, NILK-3301) for next generation immunotherapy of CEA-expressing cancers” (abstract no. 5100) was presented on site in poster section 22 (board no. 3) on April 18, 1:30 PM - 5:00 PM.
A pdf file is available for download here.
Orange County Convention Center, 9800 International Dr, 32819 Orlando, FL, USA
